ViGenCell Inc. (KOSDAQ:308080)
South Korea · Delayed Price · Currency is KRW 5,440.00
+330.00 (6.46%)
At close: Oct 16, 2026
ViGenCell Market Cap
ViGenCell has a market cap or net worth of 111.52 billion as of October 16, 2026. It is the 27,034th most valuable company in the world and the 1,232nd biggest in South Korea. Its market cap has increased by 50.85% in one year.
Market Cap
111.52B
Enterprise Value
74.22B
Revenue
278.95M
Global Rank
Country Rank
#1,232 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since August 25, 2021, ViGenCell's market cap has decreased from 561.23B to 111.52B, a decrease of -80.13%. That is a compound annual growth rate of -26.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 111.52B | -44.21% |
| Dec 30, 2025 | 199.87B | 315.01% |
| Dec 30, 2024 | 48.16B | -57.05% |
| Dec 28, 2023 | 112.12B | -17.15% |
| Dec 29, 2022 | 135.32B | -61.11% |
| Dec 30, 2021 | 347.95B | -38.00% |
| Aug 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ensol Biosciences | 140.17B |
| Kanaph Therapeutics | 133.27B |
| TiumBio | 124.81B |
| Y-Biologics | 107.57B |
| AriBioLab | 103.37B |
| Cell Biotech | 103.34B |
| Prestige Biologics | 99.83B |
| CORESTEMCHEMON | 88.23B |